导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 43.16% | 61/1050 |
| 近一周 | 6.35% | 1/1104 |
| 近一月 | -2.88% | 384/1102 |
| 近一季 | 49.25% | 3/1092 |
| 近半年 | 40.53% | 31/1070 |
| 近一年 | 26.31% | 183/1018 |
| 近两年 | 86.43% | 245/926 |
| 近三年 | 43.01% | 310/833 |
| 成立以来 | 84.80% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
3.42% 232/1070 |
10.77% 531/1101 |
- - |
- - |
| 2025 | 15.91% 740/1065 |
7.73% 241/1014 |
5.99% 241/1038 |
14.38% 754/1050 |
-11.25% 923/1065 |
| 2024 | -21.16% 913/1011 |
-12.75% 845/960 |
-7.85% 777/983 |
11.22% 528/991 |
-11.83% 952/1011 |
| 2023 | -12.75% 427/952 |
-0.84% 658/880 |
-8.29% 704/895 |
-5.12% 319/915 |
1.12% 91/952 |
| 2022 | -19.75% 318/867 |
-8.18% 70/773 |
-3.34% 741/806 |
-16.61% 656/845 |
8.44% 110/867 |
| 2021 | -7.38% 454/740 |
3.04% 80/580 |
12.21% 305/659 |
-10.12% 511/704 |
-10.88% 667/740 |
| 2020 | 94.10% 49/554 |
19.34% 9/419 |
42.51% 14/466 |
6.82% 324/517 |
6.84% 408/554 |
| 2019 | 65.83% 53/410 |
35.12% 141/1149 |
4.05% 74/1231 |
17.65% 25/390 |
0.25% 386/410 |
| 2018 | -12.51% 17/349 |
- - |
- - |
- - |
-16.80% 945/1080 |
| 2017 | 8.16% 143/285 |
- - |
- - |
- - |
- - |
| 2016 | -19.34% 116/205 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8316 | 54.00% |
| 招商前沿医疗保健股票C | 0.7978 | 53.53% |
| 招商医药健康产业股票 | 2.5730 | 49.25% |
| 广发医药精选股票C | 1.2923 | 40.43% |
| 广发医药精选股票A | 1.3132 | 38.48% |
| 嘉实医疗保健股票 | 2.5780 | 38.47% |
| 前海开源公共卫生股票A | 0.4690 | 37.42% |
| 前海开源公共卫生股票C | 0.4590 | 37.30% |
| 中欧医疗创新股票A | 1.6444 | 34.01% |
| 中欧医疗创新股票C | 1.5481 | 33.74% |
| 招商医药健康产业股票 VS. 东吴新产业精选股票A(580008) |